Twenty patients (57.14%) were found to have CK19+ cells in peripheral blood, 12 samples were CK19 positive at stage II, five samples at stage III and two samples with breast cancer at stage IV but CK19 was not detected in patients at stage I and healthy controls by flow cytometry. This evidence concerns the gene KRT19 and breast carcinoma.